selective M3 muscarinic receptor antagonist (Oriens)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameselective M3 muscarinic receptor antagonist (Oriens)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsUrinary Incontinence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOriens Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOriens Life Sciences Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Incontinence

Other Information

ATC CodeN/A
Related LinksN/A